Silencing of the F11R gene reveals a role for F11R/JAM-A in the migration of inflamed vascular smooth muscle cells and in atherosclerosis

Atherosclerosis

Volumn 212, Issue 1, 2010, Pages 197-205

  Azari, Bani M ^a   Marmur, Jonathan D ^a   Salifu, Moro O ^a   Cavusoglu, Erdal ^a   Ehrlich, Yigal H ^b   Kornecki, Elizabeth ^a   Babinska, Anna ^a  

^a SUNY DOWNSTATE MEDICAL CENTER   (United States)

^b CITY UNIVERSITY OF NEW YORK   (United States)

Author keywords

Atherosclerosis; Coronary artery disease; F11 receptor; F11R; JAM A; Migration of smooth muscle cells; Vascular smooth muscle cells

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 1BETA; JUNCTIONAL ADHESION MOLECULE A; MESSENGER RNA; SMALL INTERFERING RNA; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTERY INTIMA; ARTICLE; ATHEROGENESIS; ATHEROSCLEROTIC PLAQUE; CELL MIGRATION; CELL PROLIFERATION; CELL STIMULATION; COMPETITIVE INHIBITION; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; FEMALE; GENE SILENCING; HEART INFARCTION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; LEFT ANTERIOR DESCENDING CORONARY ARTERY; LEFT CORONARY ARTERY; MALE; PATHOPHYSIOLOGY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RIGHT CORONARY ARTERY; SMOOTH MUSCLE FIBER; STROKE; VASCULAR SMOOTH MUSCLE;

ADULT; AGED; AORTA; AUTOPSY; CELL ADHESION MOLECULES; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; CORONARY ARTERY DISEASE; CORONARY VESSELS; CYTOKINES; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNOGLOBULINS; INFLAMMATION; INFLAMMATION MEDIATORS; MALE; MICROSCOPY, CONFOCAL; MIDDLE AGED; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; POLYMERASE CHAIN REACTION; RNA INTERFERENCE; RNA, MESSENGER; TIME FACTORS; TRANSFECTION;

EID: 77956225927     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2010.05.014     Document Type: Article

References (17)

1. Ross R. Atherosclerosis is an inflammatory disease. Am Heart J 1999, 138:419-420.
2. Owens G.K., Kumar M.S., Wamhof B.R. Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol Rev 2004, 84:767-801.
3. Couffinhal T., Duplaa C., Moreau C., Lamaziere J.M., Bonnet J. Regulation of vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 in human vascular smooth muscle cells. Circ Res 1994, 74(2):225-234.
4. Kornecki E., Walkowiak B., Naik U.P., Ehrlich Y.H. Activation of human platelets by a stimulatory monoclonal antibody. J Biol Chem 1990, 265(17):10042-10048.
5. Martin-Padura I., Lostaglio S., Schneemann M., et al. Junctional adhesion molecule, a novel member of the immunoglobulin superfamily that distributes at intercellular junctions and modulates monocyte transmigration. J Cell Biol 1998, 142:117-127.
6. Ozaki H., Ishii K., Horiuchi H., et al. Cutting edge: combined treatment of TNF-alpha and IFN-gamma causes redistribution of junctional adhesion molecule in human endothelial cells. J Immunol 1999, 163(2):553-557.
7. Babinska A., Kedees M.H., Athar H., et al. F11-receptor (F11R/JAM) mediates platelet adhesion to endothelial cells: role in inflammatory thrombosis. Thromb Haemost 2002, 88(November (5)):843-850.
8. Babinska A., Azari B.M., Salifu M.O., et al. The F11 receptor (F11R/JAM-A) in atherothrombosis: overexpression of F11R in atherosclerotic plaques. Thromb Haemost 2007, 97(February (2)):272-281. [Erratum in: Thromb Haemost 2007 97(3):499].
9. Cavusoglu E., Kornecki E., Sobocka M.B., et al. Association of the F11 receptor/junctional adhesion molecule-A (F11R/JAM-A) with human atherosclerosis. JACC 2007, 50(18):1768-1776.
10. Salifu M.O., Kolff Q., Murty P., et al. Relationship between the soluble F11 receptor and markers of inflammation in hemodialysis patients. J Invest Med 2007, 55(3):115-119.
11. Ong K.L., Leung R.Y., Babinska A., et al. Elevated plasma level of soluble F11 receptor/junctional adhesion molecule-A (F11R/JAM-A) in hypertension. Am J Hypertens 2009, 22:500-505.
12. Severson E.A., Winston Y.L., Capaldo C.T., Nusrat A., Parkos C.A. Junctional adhesion molecule A interacts with afadin and PDZ-GEF2 to activate Rap1A, regulate β1 integrin levels, and enhance cell migration. Mol Biol Cell 2009, 20(7):1916-1925.
13. Strober W. Current protocols in immunology 1997, John Wiley & Sons, Inc., pp. A.3B.1-A.3B.2, Copyright © 1997.
14. Carmichael J., DeGraff W.G., Gazdar A.F., Minna J.D., Mitchell J.B. Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing. Cancer Res 1987, 47(February (4)):936-942.
15. Olofsson P.S., Söderström L.A., Wågsäter D., et al. CD137 is expressed in human atherosclerosis and promotes development of plaque inflammation in hypercholesterolemic mice. Circulation 2008, 117(10):1292-1301.
16. Gupta S.K., Pillarisetti K., Ohlstein E.H. Platelet agonist F11 receptor is a member of the immunoglobulin superfamily and identical with junctional adhesion molecule (JAM): regulation of expression in human endothelial cells and macrophages. IUBMB Life 2000, 50(1):51-56.
17. Papaspyridonos M., Smith A., Burnand K.G., et al. Novel candidate genes in unstable areas of human atherosclerotic plaques. Arterioscler Thromb Vasc Biol 2006, 26:1837-1844.